In laboratories dotted across the continent, dedicated and ingenious researchers work feverishly for years, or even careers, to increase our understanding of science at the small scale. Along the way, they develop new, innovative devices to detect pressure, acceleration, temperature or direction – and that’s just the beginning.
Researchers now explore tiny devices that eject a dose of medicine at pre-determined intervals. They create entire, micron-sized laboratories or computer systems on a chip. They are discovering just how much room there is at the small scale, as physicist Richard Feynman famously predicted almost 49 years ago.
Ugly, but it works
But innovation at the sharp end lags behind scientific advances. Often the devices only exist in the laboratory as a demonstration. These prototype lab demonstrations look ugly, but often work and they prove functionality at the nano- or micro-scale. They also often determine whether the invention will ever see the light of day.
“For certain types of device, targeting very large volumes in sectors like the automotive and, more recently, the computer gaming industry, there is a promising future,” reveals Patric Salomon, a partner with the PATENT-DfMM network of excellence (NoE). “But for many others, the lab is the only place where these devices are ever really used.”
The reason? Up to 80 percent of the unit cost for micro- and nano-devices is in the packaging and testing phase, and the unit cost must often come in under a euro. “Many innovations are just too expensive to commercialise,” notes Salomon.
But not, perhaps, for much longer. The PATENT-DfMM network was set up to find a way to cut the cost of packaging, testing and manufacturing micro and nano-devices. To do it, the 22-strong consortium had €6.2 million funding from the EU.
“We had a lot of control over how we assessed projects for funding within the network,” says Salomon. “As a result, we were able to get quite a significant impact.” In the end, the NoE supported over 60 small-scale projects.
These looked at ways to simplify the “Design for Micro Manufacture” process. In essence, researchers learn about manufacturing constraints before starting a design and they take these into account during the concept phase, to optimise units for manufacturing processes. This drives down costs and the time to market.
The network funded research into ways of re-using one design, or its building blocks, for a different type of product. It also studied more efficient ways to test for robustness and perform quality control. Already, these projects have had an important impact, though Salomon admits that they are difficult to quantify.
The end of the beginning
But that’s just the beginning. PATENT-DfMM also conceived a series of service clusters, groups of specialists in particular areas of micro- and nanotechnology, offering services in design for manufacture, testing and reliability.
“These target specifically SMEs and can provide help for companies seeking to commercialise a nano- or microtechnology,” notes Salomon. So far, PATENT-DfMM has set up two; one specialised in miniaturised health-monitoring systems (HUMS), while another focuses on reliability (EUMIREL).
In all, it offers hope of a commercial life for the thousands of lost innovations gathering dust in labs across the continent, and more importantly, to make sure future inventions are “designed for manufacture” from their initial development phase.
Christian Nielsen | ICT Results
New Foldable Drone Flies through Narrow Holes in Rescue Missions
12.12.2018 | Universität Zürich
NIST's antenna evaluation method could help boost 5G network capacity and cut costs
11.12.2018 | National Institute of Standards and Technology (NIST)
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
What if a sensor sensing a thing could be part of the thing itself? Rice University engineers believe they have a two-dimensional solution to do just that.
Rice engineers led by materials scientists Pulickel Ajayan and Jun Lou have developed a method to make atom-flat sensors that seamlessly integrate with devices...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
13.12.2018 | Life Sciences
13.12.2018 | Physics and Astronomy
13.12.2018 | Earth Sciences